Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scizeng Medical Technology is a high-tech medical device company headquartered in Suzhou, China, specializing in the development of innovative vascular interventional products. The company focuses on addressing complex clinical needs in cardiovascular care through a portfolio that includes drug-eluting stents, balloon catheters, and other interventional consumables. Their flagship products, such as rapamycin-eluting coronary stent systems, leverage advanced material science and precision manufacturing to improve outcomes for patients with coronary artery disease. Scizeng is dedicated to the localization of high-end medical consumables and has established a robust R&D and manufacturing infrastructure. Supported by prominent venture capital firms, the company continues to expand its clinical pipeline and commercial footprint within the interventional cardiology market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scizeng Medical Technology.